Outcomes With Digoxin in Atrial Fibrillation
[...]the best available evidence on clinical outcomes with digoxin in AF patients comes from post-hoc analyses of clinical trials designed to answer other questions, or from observational studies. The sample size is at least 20 times larger than any prior study on the topic, the sample is drawn from...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2014-08, Vol.64 (7), p.669-671 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [...]the best available evidence on clinical outcomes with digoxin in AF patients comes from post-hoc analyses of clinical trials designed to answer other questions, or from observational studies. The sample size is at least 20 times larger than any prior study on the topic, the sample is drawn from many clinical centers around the United States, and the time frame of observation is more contemporary than some previous studies (e.g., the AFFIRM trial). |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2014.04.070 |